2012
ESTABLISHED
Accelerating the Race Against Time
DMD Initiative Clone was founded on a simple yet powerful premise: that the path to a cure for Duchenne Muscular Dystrophy should be shorter, faster, and more inclusive. We began as a group of determined advocates and clinical experts committed to transforming medical research into tangible therapies. Our journey is defined by the synergy between community funding and high-impact clinical collaboration, ensuring every dollar spent brings us closer to a future where Duchenne is no longer a life-limiting diagnosis.
Today, we continue to lead with a first-person dedication to our mission, uniting families and medical pioneers in a race against time. We don't just fund projects; we cultivate breakthroughs that breathe hope into the lives of those affected by DMD, proving that when community and science collide, the impossible becomes achievable.
The Visionaries Behind DMD Initiative Clone
We bring together world-class medical advisors, patient advocates, and strategic partners dedicated to accelerating a cure for Duchenne Muscular Dystrophy.
Dr. Elias Vance
Medical Director
Global Advocacy Lead
Julian Ross
Sarah Sterling
Research Coordinator
Dr. Kevin Park
Therapeutics Lead
Marcus Thorne
Board Chair
Operations Director
Fiona Walsh
Dr. Maya Lin
Clinical Advisor
David Chen
Donor Relations